Mrs. Waverly Ann Dixon, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 223 N Main St, Brookfield, MO 64628 Phone: 660-258-7892 Fax: 660-258-9828 |
Stacie Nicole Malloy, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 122 N Main St, Brookfield, MO 64628 Phone: 660-258-7892 |
Brookfield Physical Therapy,inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 223 N Main St, Brookfield, MO 64628 Phone: 660-258-7892 Fax: 660-258-9829 |
Ms. Kimmy Ann Minkler, M.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 130 E Lockling St, Brookfield, MO 64628 Phone: 660-258-2222 |
Heather Martin Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 124a N Pershing Dr, Brookfield, MO 64628 Phone: 660-258-2159 Fax: 660-258-2190 |
Cassandra Jaynes, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 223 N Main St, Brookfield, MO 64628 Phone: 660-258-7892 Fax: 660-258-9829 |
Mrs. Kristen Marie Butterfield, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 116 East Pratt, Brookfield, MO 64628 Phone: 660-258-7402 Fax: 660-258-2364 |
Mr. Gary W Fite, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 130 E Lockling St, Brookfield, MO 64628 Phone: 660-258-2222 |
News Archive
Covidien, a leading global provider of healthcare products, today announced the launch of its "1 in 1,000" campaign to help educate women about the risk of pregnancy-related blood clots, one of the leading causes of maternal mortality in the developed world.
Two new retrospective subanalyses of the RE-LY trial, involving Pradaxa capsules, suggested that the reduction in stroke risk achieved with PRADAXA 150mg over warfarin occurred irrespective of CHA2DS2-VASc risk score and the type of non-valvular atrial fibrillation.
A new study reveals that insurance status, marital status, and county-level income may affect the chances of survival in young patients with acute myelogenous leukemia (AML). Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings indicate that efforts are needed to address the social factors that impact critical aspects of health in these patients.
Lancet Infectious Diseases Newsdesk examines how despite evidence that a new therapy to treat sleeping sickness, called nifurtimox—eflornithine (NECT) is a step forward in treating the disease, it has yet to be implemented by countries "13 months after data from a successful trial was presented." The main issue at hand - "nifurtimox is not registered for use in sleeping sickness," the journal writes. The article also examines other factors complicating the implementation of the therapy (Morris, 12/09).
Judith Smith, now 71, was at a routine appointment several years ago with her longtime ophthalmologist when the doctor made a comment that her right eye looked a little suspicious for glaucoma, an incurable disease that occurs when the optic nerve is damaged by pressure building inside the eye.
› Verified 2 days ago